The course will provide a broad overview of key topics in biostatistics that are frequently at the forefront of litigation involving drugs and medical devices. The course will include a review of basic concepts including relative risks, odds ratios, statistical significance and power, comparing proportions, survival analysis, Bayesian analysis, metanalysis, and common issues in trial clinical conduct. The course will also touch on how these concepts figure into judicial opinions. Participants will learn to identify common red flags and pit falls in statistical analysis, develop tools to more effectively conduct discovery and interface with experts, and develop a sense for how courts view and understand these issues.
New York City’s new Non-Primary Residence Property Surcharge—commonly known as the pied-...
Class action waivers in arbitration agreements remain enforceable, but a decade of U.S. Supreme Cour...
During this course, you will learn about best practices and strategies for retaining intellectual pr...
"Artificial Intelligence and the Practice of Law" (updated through 2026), is a 50-slide primer desig...
Class action litigation continues to expand in both number of filings and monetary exposure, with se...
Class action litigation presents significant legal and business challenges for employers and corpora...
This course on trade secrets litigation provides real-world best practices through all key stages of...
Confidentiality Agreements (also called NDAs) are too often treated as routine. So routine, th...
This course is meant for lawyers of all levels and areas of practice, and in it, we will explore way...
Adverse and derogatory information often has devastating effects on a contractor's ability to win co...